ED
MMS icon

Exane Derivatives’s Maximus MMS Stock Holding History

Exane Derivatives’s Portfolio MMS Stock Details MMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,618
Closed -$1.3M – 934
2021
Q3 		$1.3M Sell
15,618
-4,881
-24% -$418K 0.31% 68
2021
Q2 		$1.81M Buy
20,499
+4,532
+28% +$415K 0.41% 44
2021
Q1 		$1.42M Buy
15,967
+1,282
+9% +$105K 0.41% 54
2020
Q4 		$1.07M Buy
+14,685
New +$1.04M 0.32% 78

Other funds holding MMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exane Derivatives's MMS Position: Q4 2021 in Review

Exane Derivatives sold out of Maximus (MMS) in Q4 2021, closing a stake of 15,618 shares — an estimated $1.3M sold.

Exane Derivatives first reported a position in MMS in Q4 2020 and held it in 4 quarters. The position peaked at $1.81M in Q2 2021. 348 funds tracked by Wall St. Rank hold MMS as of Q4 2021.

  • Exane Derivatives reported no remaining Maximus position as of Q4 2021 after selling out during the quarter.
  • Exane Derivatives sold 15,618 Maximus shares in Q4 2021, an estimated $1.3M.
  • Exane Derivatives first reported a position in Maximus in Q4 2020 and held it in 4 quarters.
  • Exane Derivatives's Maximus position peaked at $1.81M in Q2 2021.
  • 348 funds tracked by Wall St. Rank held Maximus as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.